Attached files
| file | filename |
|---|---|
| EX-10.1 - EX-10.1 - ACHIEVE LIFE SCIENCES, INC. | d436251dex101.htm |
| EX-3.2 - EX-3.2 - ACHIEVE LIFE SCIENCES, INC. | d436251dex32.htm |
| EX-3.1 - EX-3.1 - ACHIEVE LIFE SCIENCES, INC. | d436251dex31.htm |
| 8-K - 8-K - ACHIEVE LIFE SCIENCES, INC. | d436251d8k.htm |
Exhibit 16.1
August 2, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated August 1, 2017, of OncoGenex Pharmaceuticals, Inc. and are in agreement with the statements contained in the first, second, and third paragraphs on page 3 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP